Social Capital Suvretta Holdings is a partnership between Chamath Palihapitiya, Founder and Managing Partner of Social Capital, and Kishen Mehta, Portfolio Manager of the Averill strategy at Suvretta Capital Management. Our company unites scientists, physicians, entrepreneurs and biotechnology-oriented investors around a shared vision of investing in innovative and agile biotechnology companies.

We believe that our management team’s relationships with leading biotechnology company founders, executives of private and public companies, venture capitalists and growth equity fund managers, in addition to the extensive industry and geographical reach of Social Capital and Suvretta’s networks, give us a competitive advantage in pursuing a broad range of opportunities.

Social Capital has also partnered with Hedosophia Group Limited to launch IPO 2.0, a project to chart an alternative path to a traditional IPO for disruptive technology companies. IPO 2.0 has launched six SPACs that raised over $4 billion in their IPOs; as of June 2021, four have completed successful business combinations.